Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Ritchie

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 7, 2025
Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer's disease: APOE and MAPTSamuel K Bennett, Jianmin Zeng, Maria-Eleni Dounavi, et al.
Frontiers in Neurology|June 20, 2024
Towards a lifelong personalized brain health program: empowering individuals to define, pursue, and monitor meaningful outcomesStina Saunders, Joyce Gomes-Osman, Ali Jannati, et al.
International Journal of Geriatric Psychiatry|October 29, 2025
Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With NeurodegenerationCatherine Pennington, Harriet Ball, Peter Connelly, et al.
BMC Ophthalmology|February 6, 2022
Measuring axial length of the eye from magnetic resonance brain imagingStewart J Wiseman, Andrew J Tatham, Rozanna Meijboom, et al.
Digital Biomarkers|December 5, 2022
Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 FrameworkJohannes Tröger, Ebru Baykara, Jian Zhao, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy IndividualsRichard Milne, Eline Bunnik, Ana Diaz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratiosFemke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
The Journal of Prevention of Alzheimer'S Disease|March 26, 2026
Performance of a fully automated plasma tau phosphorylated at threonine 217 immunoassay to reflect amyloid-beta burden in an unselected cohort representative of clinical practiceSayuri Hortsch, Annunziata Di Domenico, Niels Borlinghaus, et al.
International Journal of Geriatric Psychiatry|February 16, 2026
Estimating the Future Health and Social Care Costs of Alzheimer's Disease Dementia in the UK: Impact of Disease Modifying Therapy Efficacy, Uptake, and Care Model - A Scenario Modelling StudyMarc Evans, Craig Ritchie, Dominic Trepel, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsAndré Strydom, Antonia Coppus, Rafael Blesa, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 7, 2025
Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer's disease: APOE and MAPTSamuel K Bennett, Jianmin Zeng, Maria-Eleni Dounavi, et al.
Frontiers in Neurology|June 20, 2024
Towards a lifelong personalized brain health program: empowering individuals to define, pursue, and monitor meaningful outcomesStina Saunders, Joyce Gomes-Osman, Ali Jannati, et al.
International Journal of Geriatric Psychiatry|October 29, 2025
Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With NeurodegenerationCatherine Pennington, Harriet Ball, Peter Connelly, et al.
BMC Ophthalmology|February 6, 2022
Measuring axial length of the eye from magnetic resonance brain imagingStewart J Wiseman, Andrew J Tatham, Rozanna Meijboom, et al.
Digital Biomarkers|December 5, 2022
Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 FrameworkJohannes Tröger, Ebru Baykara, Jian Zhao, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy IndividualsRichard Milne, Eline Bunnik, Ana Diaz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratiosFemke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
The Journal of Prevention of Alzheimer'S Disease|March 26, 2026
Performance of a fully automated plasma tau phosphorylated at threonine 217 immunoassay to reflect amyloid-beta burden in an unselected cohort representative of clinical practiceSayuri Hortsch, Annunziata Di Domenico, Niels Borlinghaus, et al.
International Journal of Geriatric Psychiatry|February 16, 2026
Estimating the Future Health and Social Care Costs of Alzheimer's Disease Dementia in the UK: Impact of Disease Modifying Therapy Efficacy, Uptake, and Care Model - A Scenario Modelling StudyMarc Evans, Craig Ritchie, Dominic Trepel, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsAndré Strydom, Antonia Coppus, Rafael Blesa, et al.
Pageof 13